You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Dow
McKesson
Harvard Business School
McKinsey

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

Litigation Details for PAR PHARMACEUTICAL, INC. v. QUVA PHARMA, INC. (D.N.J. 2017)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

PAR PHARMACEUTICAL, INC. v. QUVA PHARMA, INC. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-08-14
Court District Court, D. New Jersey Date Terminated
Cause 18:1836(b) Civil Action to Protect Trade Secrets Assigned To Brian R. Martinotti
Jury Demand Plaintiff Referred To Douglas E. Arpert
Parties BAIN CAPITAL; DAVID HARTLEY; DAVID SHORT; DONNA KOHUT; MIKE RUTKOWSKI; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC; PETER JENKINS; QUVA PHARMA, INC.; STEPHEN RHOADES; STUART HINCHEN; TRAVIS MCGRADY
Patents 7,015,018; 9,375,478; 9,687,526; 9,744,209; 9,744,239; 9,750,785
Attorneys ANN ELIZABETH QUERNS; ANN MARIE EFFINGHAM; BENJAMIN JAMES DILORENZO; DANIEL J. MCGRADY; DAVID C. KISTLER; DAVID LEIT; DIANA C. MANNING; JARRETT R. SCHINDLER; JASON ROBERT HALPIN; JED L. MARCUS; KATE ELIZABETH JANUKOWICZ; LAWRENCE S. LUSTBERG; LEIGH ANN BUZIAK; MICHAEL RAY DARBEE; STEPHEN M. ORLOFSKY
Firms Ann Elizabeth Querns; Bressler, Amery & Ross, P.C.; Bressler, Amery & Ross, Pc; Bressler, Amery, & Ross; Lowenstein Sandler; Lowenstein Sandler PC
Link to Docket External link to docket
Small Molecule Drugs cited in PAR PHARMACEUTICAL, INC. v. QUVA PHARMA, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in PAR PHARMACEUTICAL, INC. v. QUVA PHARMA, INC.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for PAR PHARMACEUTICAL, INC. v. QUVA PHARMA, INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 136 are: (1) U.S. Patent No. 9,375,478; (2) U.S. Patent No. 9,687,526; (3) U.S. Patent No. 9,744,239; (4) …any of five patents Par purports to own in connection with Vasostrict®. 5 5 The patents at issue are…) U.S. Patent No. 9,744,209; and (5) U.S. Patent No. 9,750,785. External link to document
0000-00-00 249 Brief are listed below: • U.S. Patent No. 9,375,478 (“the ’478 patent”), which issued on June 28, …and Par itself. By definition, Par’s own patents 1 and patent applications covering its product are the… at least five patents relating to its vasopressin injection product. These patents, with their corresponding…previously published; • U.S. Patent No. 9,687,526 (“the ’526 patent”), which issued on June 27, …February 9, 2017; • U.S. Patent No. 9,744,239 (“the ’239 patent”), which issued on August 29, External link to document
2018-06-18 251 Brief explained by QuVa’s expert Dr. Mohan Rao. (Id. ¶¶ 7, 15, 18-25, 30.) Indeed, both experts agree that, in this…consist of information in Par’s own patent and published patent application, as well general knowledge…published U.S. Patent Application No. 2017/0290881 (the “’881 publication”), Par’s U.S. Patent No. 9,375,478…which is disclosed in an issued patent or in a published patent application, is not secret and thus…9,375,478 (the “’478 patent”), and other public information disclose a majority of Par’s vasopressin External link to document
0000-00-00 252 Brief 219 is a true and correct copy of U.S. Patent 9,375,478 to Kenney et al., as produced as QuVa007870…Hinchen 11-10-2017 219 U. S. Patent 9,375,478 Kenney et al. 06-28-2016…as Exhibit 210 is a true and correct copy of US Patent Application Publication 2017/0290881 A1 (Kannan… QuVa007762 210 US Patent Application Publication 2017/0290881 A1 10-12 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Express Scripts
Mallinckrodt
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.